1. Introduction {#sec1}
===============

When patients are infected with HIV, their disease process can be best characterized along a continuum from rapid progressors to HIV long-term nonprogressors (LTNPs). Subsets of these patients are characterized as rapid progressors, in which they develop AIDS within a few years, often less than 5 years. In contrast, long-term nonprogressors are those in which AIDS develop many years after being infected with HIV, often beyond the 10-year mark, and represent 15--20% of the HIV infected patients. LTNPs are a subset of long-term nonprogressors, generally referred to as individuals who have contracted the HIV infection but control their infection and maintain undetectable viral loads for long periods of time without antiretroviral therapy \[[@B1]\].

During our literature search, we found extensive data related to HIV LTNPs in the adult population; however, very limited data was available related to LTNPs within the pediatric population. It is important not to confuse pediatric LTNPs with pediatric slow progressors, as the latter is referred to a group of HIV-1-infected pediatric individuals who are homogeneous for route and length of infection and standard of care, thereby having disease progression requiring antiretroviral therapy at some point of their lives. We present a case of pediatric HIV LTNPs, perinatally infected patient with undetectable viral loads, despite never receiving ART.

2. Case Report {#sec2}
==============

A 14-year-old female with a history of HIV acquired via vertical transmission from a noncompliant, advanced AIDS-infected mother presented to our tertiary care hospital. She had no siblings and lived with her mother for the first two years after birth until her mother died of an AIDS-associated infection. Information regarding the HIV status of her biological father was unknown, as this individual was never involved in her care. She missed all her medical appointments while living with her mother. Afterwards, she resided with her maternal grandparents. At that time, she had her first medical evaluation without prior antepartum medical records, where an ELISA and western-blot test were done and came back positive. Her HIV-1 plasma viral load was 1,050-copies/mL and a CD4 count was 2,869 cells per cubic millimeter of blood (CUMM). HIV-1/2 antibody testing confirmed an HIV-1 infection.

She was transferred to an HIV satellite clinic and later to our tertiary infectious disease adolescent clinic. She had never taken ART prior to her MUSC visit. Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"} demonstrate the values of her immunodeficiency panel as well as her HIV-1 viral load since initiation of care at our center. Her repeat HIV-1 plasma RNA viral load was 632-copies/mL with a CD4 count of 2,364/cumm. She was monitored clinically without ART and serial repeat laboratory tests were performed.

Her HIV-1 plasma viral load remained undetectable and her viral load remained dramatically unchanged. Repeat ELISA and western blot testing performed on a yearly basis since initial HIV diagnosis have been positive ([Table 2](#tab2){ref-type="table"}). Of note, further investigation was significant for a positive human leukocyte antigen B27 test; however, no deletions or mutations were appreciated. Additional testings for ankylosing spondylitis, reactive arthritis, sacroiliitis, uveitis, and other conditions known to have a positive HLA-B27 antigen test were negative. Proviral HIV tropism testing confirmed a CCR5-tropic (R5) using HIV-1 virus.

Two years later, her viral load rose to 614-copies/mL of plasma. Her viral load remained between undetectable and 727-copies/mL and her CD4 ranged from 1151 to 2186/cumm despite not being initiated on ART. Since 2005, it has remained undetectable without ART. With respect to her overall general clinical course, she has not had any complicating opportunistic infections, hospitalizations, or complications related to HIV. She is a hitherto fit girl, with all the appropriate signs of puberty and sexual development for her age group, including her height and weight.

3. Discussion {#sec3}
=============

Pediatric long-term nonprogressors (LTNPs) are individuals infected with HIV-1 who maintain a suppressed viral load, which refers to either an undetectable viral load (HIV RNA \<20 to 75 copies/mL) or a low-detectable HIV-RNA viral load (typically HIV RNA \<200 copies/mL), depending on the sensitivity of the HIV RNA assay that is used, despite not being on ART \[[@B2]\]. The clinical relevance of the LTNP classification is not well understood, as some patients remain virologically suppressed, while others have gone on to develop AIDS. LTNPs generally remain at a certain viral load despite not receiving ART \[[@B1]\]. Unlike patients with a "functional" cure, these patients are once known to have detectable HIV-1 RNA viral loads, similar to our index case of \~20,000 copies/mL of plasma, and have spontaneously suppressed their viral load and maintained a stable CD4 count without ART influence. Of importance, in comparison to LTNPs, patients with a "functional" cure would test negative for HIV at some point of their care, whereas LTNPs will always have a positive HIV test \[[@B2]\].

After acquisition of HIV, the virus naturally enters into human cells and attach to proteins on that cell. HIV tropism testing allows for knowledge to the type of protein that HIV attaches to. These proteins are the CCR5 and CXCR4, and most HIV infections are caused by the CCR5-using virus; however, as HIV reproduces, it may change from a CCR5-using virus to a CXCR4-using virus. Mutations or deletions in these proteins can account for why an HIV-infected individual rarely progresses to AIDS. Our index patient had a CCR5-tropic using HIV-1 virus.

Different etiologies have been studied which allows long-term nonprogressors to go live without taking ART. These etiologies consist of gene and receptor mutations \[[@B3]\], various mitochondrial DNA types \[[@B4]\], and different human leukocyte antigen (HLA) types, specifically HLA-B27 or HLA-B57 \[[@B5]\]. Perinatally infected children with HIV may acquire the same genes and HLA as their mothers. However, since differences in transcriptional regulation have been observed among different HIV-1 subtypes, the viruses may also be very different. With our index patient, whose mother died secondary to opportunistic infections complicating her advanced AIDS, HLA antigen testing was positive for HLA-B27; however, no deletion or mutation was appreciated.

One question that arises is, was her biological father also HIV-infected? And if so, the possibility of this patient acquiring a mutated HLA B27 gene must be entertained. Unfortunately, her biological father was not involved in her care and his exact presence was unknown; therefore, testing for this was not available and therefore would remain a mystery. Although there are not many instances of LTNPs among children, this child may be one, though she had intermittent viremia. She has continued to manifest serologic evidence of infection, with yearly ELISA and western blot positive tests. Based on the viral fitness studies that were performed, this case exemplifies an adolescent LTNP.
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###### 

Clinical laboratory results: CD4/CD8 values.

  Date         CD3%   ^€^CD3 absolute \#   CD4%   ^€^CD4 absolute \#   CD8%   ^€^CD8 absolute \#   CD4/CD8 ratio
  ------------ ------ -------------------- ------ -------------------- ------ -------------------- ---------------
  05/07/2009   72     2106                 40     1151                 29     842                  1.4
  01/08/2009   74     2049                 44     1229                 26     713                  1.7
  08/28/2008   74     1967                 43     1152                 26     699                  1.7
  05/29/2008   75     1736                 50     1149                 22     510                  2.3
  03/09/2006   73     2240                 47     1431                 21     649                  2.2
  11/10/2005   72     2233                 44     1359                 22     689                  2.0
  07/21/2005   72     2562                 43     1482                 26     903                  1.6
  12/02/2004   74     2806                 42     1681                 23     928                  1.8
  03/11/2004   71     3370                 51     2186                 21     912                  2.4
  04/14/2003   80     3194                 43     1890                 23     1041                 1.8
  12/09/2002   72     3779                 43     2153                 26     1310                 1.6
  08/19/2002   75     3976                 44     2338                 25     1327                 1.8
  04/15/2002   74     3798                 39     2120                 24     1328                 1.6
  01/07/2002   72     3989                 45     2517                 21     1189                 2.1
  11/01/2001   62     3699                 31     1852                 25     1496                 1.2
  08/09/2001   68     5386                 37     2971                 23     1868                 1.6
  05/23/2001   69     4821                 31     2686                 25     1752                 1.3
  02/12/2001   70     3706                 44     2364                 20     1076                 2.2

^€^mm^3^: cells per cubic millimeter.

*n*: normal reference interval for patient\'s age (Medical University of South Carolina).

###### 

Clinical laboratory results: HIV viral load.

  Date         HIV-1 plasma viral load   ELISA/western blot testing
  ------------ ------------------------- ----------------------------
  05/07/2009   UD^¥^                     Positive
  01/08/2009   UD                        Not performed
  08/28/2008   UD                        Positive
  05/29/2007   UD                        Positive
  03/09/2006   UD                        Positive
  11/10/2005   UD                        Positive
  07/21/2005   726                       Not performed
  12/02/2004   320                       Not performed
  03/11/2004   476                       Positive
  04/14/2003   614                       Positive
  12/09/2002   UD                        Not performed
  08/19/2002   UD                        Not performed
  04/15/2002   UD                        Not performed
  01/07/2002   UD                        Positive
  10/01/2001   UD                        Not performed
  07/09/2001   UD                        Not performed
  04/23/2001   UD                        Not performed
  02/12/2001   632                       Positive

^¥^UD: undetectable HIV-1 plasma viral load/copies per milliliter.

*n*: normal reference interval (Medical University of South Carolina).

Threshold for detection is any HIV-1 viral load \>40 copies/mL.

Method used to quantify HIV-1 plasma RNA viral load: real time PCR.
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